Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial.
Lin Y, Qin S, Li Z, Yang H, Fu W, Li S, Chen W, Gao Z, Miao W, Xu H, Zhang Q, Zhao X, Bao J, Li L, Ren Y, Lin C, Jing S, Ma Q, Liang J, Chen G, Zhang H, Zhang Y, Zhou X, Sang Y, Hou Z. Lin Y, et al. Among authors: fu w. JAMA Oncol. 2022 Feb 1;8(2):242-250. doi: 10.1001/jamaoncol.2021.6268. JAMA Oncol. 2022. PMID: 34913959 Free PMC article. Clinical Trial.
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.
Lin Y, Qin S, Yang H, Shi F, Yang A, Han X, Liu B, Li Z, Ji Q, Tang L, Deng Z, Ding Y, Fu W, Xie X, Li L, He X, Lv Z, Ma Q, Shen Z, Guo Z, Chen Z, Cui Y, Tan J, Gao Z, Jing S, Lu K, Luo X, Zhang Y, Fang Y, Li Z, Cheng Y, Lei S, Luan S, Chen G, Wang G, Wu L, Liu L. Lin Y, et al. Among authors: fu w. Clin Cancer Res. 2023 Aug 1;29(15):2791-2799. doi: 10.1158/1078-0432.CCR-22-3613. Clin Cancer Res. 2023. PMID: 37184934 Clinical Trial.
Recombinant Human Thyrotropin Plus Radioactive Iodine Among Patients With Thyroid Cancer: A Noninferiority Randomized Clinical Trial.
Tan H, Gu Y, Xiu Y, Han X, Wen Q, Lv Z, Fan W, Li S, Tan J, Wang F, Fu W, Zhang Y, Xin J, Ouyang W, Wang X, Liu B, Chen Y, Liu X, Mo Y, Luo Q, Wang J, Li M, Di Y, Xu T, Shi H. Tan H, et al. Among authors: fu w. JAMA Netw Open. 2024 Nov 4;7(11):e2443407. doi: 10.1001/jamanetworkopen.2024.43407. JAMA Netw Open. 2024. PMID: 39509132 Free PMC article. Clinical Trial.
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.
Wiley HE, Srinivasan R, Maranchie JK, Chhablani J, Iversen ABB, Kruse A, Jonasch E, Gombos DS, Else T, Demirci H, Maughan BL, Hartnett ME, Coleman HR, Fu W, Perini RF, Liu Y, Linehan WM, Chew EY; LITESPARK-004 Investigator Group - Ocular VHL. Wiley HE, et al. Among authors: fu w. Ophthalmology. 2024 Nov;131(11):1324-1332. doi: 10.1016/j.ophtha.2024.05.024. Epub 2024 Jun 6. Ophthalmology. 2024. PMID: 38849055 Clinical Trial.
Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1.
Cai Z, Xia Z, He AL, Dong YJ, Wang Y, Liao A, Song Y, Song Mm J, Uhlar C, Chastain K, Watkins L, Luo X, Huang L, Niu Z, Quijano Cardé NA, Guo Y, Xu H, Verona RI, Zhou L, Li J, Fu W, Niu T, Du J. Cai Z, et al. Among authors: fu w. Cancer. 2024 Dec 11. doi: 10.1002/cncr.35665. Online ahead of print. Cancer. 2024. PMID: 39660861
Transethnic analysis identifies SORL1 variants and haplotypes protective against Alzheimer's disease.
Zhou X, Cao H, Jiang Y, Chen Y, Zhong H, Fu WY, Lo RMN, Wong BWY, Cheng EYL, Mok KY, Kwok TCY, Mok VCT, Ip FCF; Alzheimer's Disease Neuroimaging Initiative; Miyashita A, Hara N, Ikeuchi T, Hardy J, Chen Y, Fu AKY, Ip NY. Zhou X, et al. Among authors: fu wy. Alzheimers Dement. 2024 Dec 10. doi: 10.1002/alz.14214. Online ahead of print. Alzheimers Dement. 2024. PMID: 39655505
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study.
Zhao Y, Xiong S, Ren Q, Wang J, Li M, Yang L, Wu D, Tang K, Pan X, Chen F, Wang W, Jin S, Liu X, Lin G, Yao W, Cai L, Yang Y, Liu J, Wu J, Fu W, Sun K, Li F, Cheng B, Zhan S, Wang H, Yu Z, Liu X, Zhong R, Wang H, He P, Zheng Y, Liang P, Chen L, Hou T, Huang J, He B, Song J, Wu L, Hu C, He J, Yao J, Liang W. Zhao Y, et al. Among authors: fu w. Lancet Oncol. 2024 Dec 6:S1470-2045(24)00599-0. doi: 10.1016/S1470-2045(24)00599-0. Online ahead of print. Lancet Oncol. 2024. PMID: 39653054
6,358 results